Optometrists have access to many new meds right now, with a flood of more on the way. Here’s a comprehensive review of what’s out now and what’s in the pipeline.
Two experts share their best “dos and don'ts” to help you confidently handle the most common scenarios across several different categories of medications.
A once-simple treatment protocol has gotten more sophisticated—and complicated—by novel drug compounds, varied dosing regimens and sustained-release delivery methods. Here’s the current state of affairs.
With one med available and others coming soon, patients have more options than ever for near vision correction. Do they offer enough to make a difference in a well-established market?